| 1 |
27796444 | Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration. | 2017 Mar |
3 |
| 2 |
25362221 | Effect of raloxifene on parathyroid hormone in osteopenic and osteoporotic postmenopausal women with chronic kidney disease stage 5. | 2014 Nov |
1 |
| 3 |
19150421 | Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone. | 2009 Apr |
2 |
| 4 |
17929072 | Effect of prior and ongoing raloxifene therapy on response to PTH and maintenance of BMD after PTH therapy. | 2008 Apr |
5 |
| 5 |
17823083 | Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis. | 2007 Sep |
1 |
| 6 |
15279072 | Effect of raloxifene and its interaction with human PTH on bone formation. | 2004 May |
2 |
| 7 |
11380487 | Effects of the selective oestrogen receptor modulator-raloxifene-on calcium and PTH secretory dynamics in women with osteoporosis. | 2001 May |
6 |